@article{daedab0458c74522b7245bcf4577e298,
title = "Chronic myelogenous leukemia",
keywords = "BCR-ABL, Chronic myelogenous leukemia, Dasatinib, Imatinib, NCCN clinical practice guidelines, NCCN guidelines, Nilotinib, Stem cell transplant, Tyrosine kinase inhibitor",
author = "Susan O'Brien and Abboud, {Camille N.} and Mojtaba Akhtari and Jessica Altman and Ellin Berman and DeAngelo, {Daniel J.} and Steven Devine and Fathi, {Amir T.} and Jason Gotlib and Madan Jagasia and Moore, {Joseph O.} and Javier Pinilla-Ibarz and Radich, {Jerald P.} and Reddy, {Vishnu V.B.} and Shah, {Neil P.} and Shami, {Paul J.} and Smith, {B. Douglas} and Snyder, {David S.} and Meir Wetzler and Furhan Yunus",
year = "2012",
month = jan,
day = "1",
doi = "10.6004/jnccn.2012.0009",
language = "English (US)",
volume = "10",
pages = "64--110",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",
}